US$ 21.63
glp 1 and aging Body-wide multi-omic counteraction of with GLP-1R agonism A new study from UC
Description
On 7.2mg dose 33% loss that much, and only 17% lost that much on 2.4mg
N Engl J Med 2024

I wanna be honest about my struggles with it with people

so yeah

Comparing Semaglutide with Tirzepatide When Diverticulitis Is a Factor Tirzepatide, another GLP-1 therapy available through PlexusDx, activates both GLP-1 and GIP receptors, potentially offering an alternative if standard semaglutide causes excessive bowel slowing
This suggested that Exendin-4-Fc may be appropriate for therapeutic application as a GLP-1 receptor agonist